Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly

• Hoofdauteurs: Peter Vink (Auteur), Masanari Shiramoto (Auteur), Masayuki Ogawa (Auteur), Masahiro Eda (Auteur), Martine Douha (Auteur), Thomas Heineman (Auteur), Himal Lal (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2017-03-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The impact of alternate routes of vaccine administration, subcutaneous (SC) or intramuscular (IM), on the safety and immunogenicity of herpes zoster subunit candidate vaccine (HZ/su) was assessed in Japanese adults aged ≥ 50 y. During this phase III open-label study, 60 subjects were randomized (1:1...